TALIA, MARIANNA
 Distribuzione geografica
Continente #
NA - Nord America 486
EU - Europa 377
AS - Asia 51
AF - Africa 16
SA - Sud America 2
OC - Oceania 1
Totale 933
Nazione #
US - Stati Uniti d'America 483
IT - Italia 133
AT - Austria 91
UA - Ucraina 51
DE - Germania 38
SE - Svezia 30
CN - Cina 20
SN - Senegal 15
GB - Regno Unito 9
FI - Finlandia 8
HK - Hong Kong 8
KR - Corea 8
FR - Francia 7
NL - Olanda 6
SG - Singapore 6
IN - India 5
TR - Turchia 4
BE - Belgio 3
CA - Canada 3
EC - Ecuador 2
AU - Australia 1
BY - Bielorussia 1
ZA - Sudafrica 1
Totale 933
Città #
Chandler 128
Vienna 70
New York 38
San Mateo 33
Ashburn 28
Rende 18
Jacksonville 16
Dakar 15
Shanghai 14
Florence 13
Lawrence 13
Bremen 12
Brooklyn 11
Dearborn 11
Roxbury 11
Seattle 11
Amantea 9
Des Moines 8
Helsinki 8
Seoul 8
Ann Arbor 7
Bari 6
Hong Kong 6
Ogden 6
Carovigno 4
Edinburgh 4
Portoferraio 4
Pune 4
Redwood City 4
San Francisco 4
Singapore 4
Brussels 3
Izmir 3
Nantes 3
Nocera Terinese 3
Palermo 3
Redmond 3
Rome 3
Sittard 3
Barnsley 2
Beijing 2
Boydton 2
Cappelle sul Tavo 2
Catanzaro 2
Cosenza 2
Genoa 2
Guayaquil 2
Houston 2
Ottawa 2
Paternò 2
Princeton 2
San Jose 2
Taurianova 2
Utrecht 2
Venice 2
Venosa 2
Vibo Valentia 2
Berlin 1
Bradford 1
Central 1
Chiswick 1
Como 1
Courbevoie 1
Enfield 1
Esslingen am Neckar 1
Frankfurt am Main 1
Haikou 1
Hefei 1
Jinan 1
Johannesburg 1
Lodi 1
Melbourne 1
Minsk 1
Montalto Uffugo 1
Nanjing 1
Paris 1
Sanayi 1
Toronto 1
Viareggio 1
Wilmington 1
Totale 611
Nome #
GPER Mediates a Feedforward FGF2/FGFR1 Paracrine Activation Coupling CAFs to Cancer Cells Toward Breast Tumor Progression 108
Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells 104
miR-338-3p Is Regulated by Estrogens through GPER in Breast Cancer Cells and Cancer-Associated Fibroblasts (CAFs) 78
Focal Adhesion Kinase Fine Tunes Multifaced Signals toward Breast Cancer Progression 72
The G Protein-Coupled Estrogen Receptor (GPER) Expression Correlates with Pro-Metastatic Pathways in ER-Negative Breast Cancer: A Bioinformatics Analysis 65
Activation of the s100a7/rage pathway by igf-1 contributes to angiogenesis in breast cancer 64
S100A4 Is Involved in Stimulatory Effects Elicited by the FGF2/FGFR1 Signaling Pathway in Triple-Negative Breast Cancer (TNBC) Cells 64
Estrogen receptor variant ERα46 and insulin receptor drive in primary breast cancer cells growth effects and interleukin 11 induction prompting the motility of cancer‐associated fibroblasts 56
IGF-1/IGF-1R/FAK/YAP Transduction Signaling Prompts Growth Effects in Triple-Negative Breast Cancer (TNBC) Cells 54
The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs) 52
Focal Adhesion Kinase (FAK)-Hippo/YAP transduction signaling mediates the stimulatory effects exerted by S100A8/A9-RAGE system in triple-negative breast cancer (TNBC) 45
Newly Synthesized Imino-Derivatives Analogues of Resveratrol Exert Inhibitory Effects in Breast Tumor Cells 44
The AGEs/RAGE Transduction Signaling Prompts IL-8/CXCR1/2-Mediated Interaction between Cancer-Associated Fibroblasts (CAFs) and Breast Cancer Cells 42
Metformin counteracts stimulatory effects induced by insulin in primary breast cancer cells 39
The Ephrin tyrosine kinase a3 (EphA3) is a novel mediator of RAGE-prompted motility of breast cancer cells 30
Identification of a human estrogen receptor α tetrapeptidic fragment with dual antiproliferative and anti-nociceptive action 27
GPER deletion triggers inhibitory effects in triple negative breast cancer (TNBC) cells through the JNK/c-Jun/p53/Noxa transduction pathway 18
RAGE inhibition blunts insulin-induced oncogenic signals in breast cancer 11
Totale 973
Categoria #
all - tutte 6.219
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.219


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20195 0 0 0 0 0 0 0 0 0 1 3 1
2019/202051 4 3 0 3 3 10 5 4 8 3 6 2
2020/202168 6 0 6 10 3 10 1 18 3 10 1 0
2021/2022187 3 25 1 24 21 6 6 37 3 1 22 38
2022/2023355 33 48 20 67 37 32 3 29 36 13 30 7
2023/2024276 60 28 21 14 21 57 13 31 20 11 0 0
Totale 973